PRECIPIO, INC. Interest Income (Expense), Nonoperating, Net
PRECIPIO, INC. (PRPO) reported Interest Income (Expense), Nonoperating, Net of -$9.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-14
- PRECIPIO, INC. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was -$9.00K.
- PRECIPIO, INC. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was -$15.00K.
- PRECIPIO, INC. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was -$16.00K.
- PRECIPIO, INC. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was -$9.00K.
- PRECIPIO, INC. interest income (expense), nonoperating, net for fiscal 2025 was -$73.00K.
- PRECIPIO, INC. interest income (expense), nonoperating, net for fiscal 2024 was -$74.00K.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$9.00K 10-Q · filed 2026-08-14 | -$24.00K 10-Q · filed 2026-08-14 | -$40.00K derived: sum of 3 quarters · filed 2026-08-14 | -$49.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$15.00K 10-Q · filed 2026-05-14 | -$31.00K derived: sum of 2 quarters · filed 2026-05-14 | -$40.00K derived: sum of 3 quarters · filed 2026-05-14 | -$63.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$25.00K derived: sum of 2 quarters · filed 2026-03-30 | -$48.00K derived: sum of 3 quarters · filed 2026-08-14 | -$73.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$9.00K 10-Q · filed 2025-11-14 | -$32.00K derived: sum of 2 quarters · filed 2026-08-14 | -$57.00K 10-Q · filed 2025-11-14 | -$86.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$23.00K 10-Q · filed 2026-08-14 | -$48.00K 10-Q · filed 2026-08-14 | -$77.00K derived: sum of 3 quarters · filed 2026-08-14 | -$106.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$25.00K 10-Q · filed 2026-05-14 | -$54.00K derived: sum of 2 quarters · filed 2026-05-14 | -$83.00K derived: sum of 3 quarters · filed 2026-05-14 | -$94.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$58.00K derived: sum of 2 quarters · filed 2026-03-30 | -$69.00K derived: sum of 3 quarters · filed 2026-03-30 | -$74.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$29.00K 10-Q · filed 2025-11-14 | -$40.00K derived: sum of 2 quarters · filed 2025-11-14 | -$45.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$11.00K 10-Q · filed 2025-08-13 | -$16.00K 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |